Insider buying
~$40K40K sh @ $1.00
Traded Nov 16 · filed 1 day later
The CEO of Maia Biotechnology paid $40K out of pocket for Maia Biotechnology shares. 1 other person at Maia Biotechnology bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 16, 2026 · Filed Nov 17, 2026
A Maia Biotechnology director paid $19K out of pocket for Maia Biotechnology shares. 1 other person at Maia Biotechnology bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$18,782
Shares × reported transaction price
Stan Smith, Director's past purchases, 90 days after disclosure: 11 buys, median −10.1 pts vs S&P 500, beat it 4 of 11 times. Past results, not a forecast.
<$25K
+1.2%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 17 earlier confirmed purchases
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $1.01 on Nov 16, 2026, 16% above its 52-week low and 66% below its high, after a 14% drop over the previous 30 trading days
52-week range $0.871 (Nov 20, 2025) to $2.95 (Jan 27, 2026), 7% of the way up, from 251 adjusted closes. 30 trading days earlier: $1.18 on Oct 5, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider buying
Traded Nov 16 · filed 1 day later
The CEO of Maia Biotechnology paid $40K out of pocket for Maia Biotechnology shares. 1 other person at Maia Biotechnology bought some too, in the same month.
Insider buying
Traded Nov 13 · filed 4 days later
A Maia Biotechnology director paid $81K out of pocket for Maia Biotechnology shares. 1 other person at Maia Biotechnology bought some too, in the same month. Shares held went up 5% with this purchase.
Insider buying
Traded Nov 13 · filed 4 days later
The CEO of Maia Biotechnology paid $60K out of pocket for Maia Biotechnology shares. 1 other person at Maia Biotechnology bought some too, in the same month. Shares held went up 6% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.